Paromomycin and geneticin inhibit intracellular Cryptosporidium parvum without trafficking through the host cell cytoplasm: Implications for drug delivery

Infection and Immunity

Volumn 66, Issue 8, 1998, Pages 3874-3883

  Griffiths, Jeffrey K ^a,b,c   Balakrishnan, Ramaswamy ^a   Widmer, Giovanni ^a   Tzipori, Saul ^a,b  

^a TUFTS UNIVERSITY   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMICROBIAL ACTIVITY; ARTICLE; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DRUG DELIVERY SYSTEM; MICROBIAL GROWTH; PRIORITY JOURNAL;

EID: 0031823634     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.66.8.3874-3883.1998     Document Type: Article

References (42)

1. Adams, R. O. B., R. L. Guerrant, S. Zu, G. Fang, and J. K. Roche. 1994. Cryptosporidium parvum infection of intestinal epithelium: morphological and functional studies in an in vitro model. J. Infect. Dis. 169:170-177.
2. Artursson, P., and J. Karlsson. 1991. Correlation between oral drug absorption in humans and apparent drug permeability coefficients in human intestinal epithelial (Caco-2) cells. Biochem. Biophys. Res. Commun. 175:880-885.
3. Ballistini, C., G. Franceschi, F. Zarini, G. Cassinelli, F. Arcamone, and A. Sanfilippo. 1982. Semisynthetic aminoglycoside antibiotics. IV. 3′4′-Dideoxyparomomycin and analogues. J. Antibiot. 35:98-101.
4. Bissuel, F., F. Cotte, M. Michele de Montclos, M. Rabodonirina, and C. Trepo. 1994. Absence of systemic absorption of oral paromomycin during long-term, high-dose treatment for cryptosporidiosis in AIDS. J. Infect. Dis. 170:749-750.
5. Blanshard, C., A. M. Jackson, D. C. Shanson, N. Francis, and B. G. Gazzard. 1992. Cryptosporidiosis in HIV-seropositive patients. Q. J. Med. 85:813-823.
6. Buchanan, J. H., S. I. S. Rattan, A. Stevens, and R. Holliday. 1982. Intracellular accumulation of a fluorescent derivative of paromomycin in human fibroblasts. J. Cell. Biochem. 20:71-80.
7. Buchanan, J. H., A. Stevens, and J. Sidhu. 1987. Aminoglycoside antibiotic treatment of human fibroblasts: intracellular accumulation, molecular changes and the loss of ribosomal accuracy. Eur. J. Cell Biol. 43:141-147.
8. Cai, J., M. D. Collins, V. McDonald, and G. H. Mitchell. 1992. PCR cloning and nucleotide sequence determination of the 18S rRNA genes and internal transcribed spacer 1 of the protozoan parasites Cryptosporidium parvum and Cryptosporidium muris. Biochim. Biophys. Acta 1131:317-320.
9. Capmau, M.-L., B. Moreau, and F. Le Goffic. 1983. A one pot tritiation of aminoglycoside antibiotics. J. Antibiot. 36:735-737.
10. Current, W. L. 1990. Techniques and laboratory maintenance of Cryptosporidium, p. 41-44. In J. P. Dubey, C. A. Speer, and R. Fayer (ed.), Cryptosporidiosis of man and animals. CRC Press, Boca Raton, Fla.
11. Current, W. L., and L. S. Garcia. 1991. Cryptosporidiosis. Clin. Microbiol. Rev. 4:325-358.
12. Current, W. L., and N. C. Reese. 1986. A comparison of endogenous development of three isolates of Cryptosporidium in suckling mice. J. Protozool. 33:98-108.
13. Davies, J., and A. Jimenez. 1980. A new selective agent for eukaryotic cloning vectors. Am. J. Trop. Med. Hyg. 29:1089-1092.
14. Donald, R. G., and D. S. Roos. 1993. Stable molecular transformation of Toxoplasma gondii: a selectable dihydrofolate reductase-thymidylate synthase marker based on drug-resistance mutations in malaria. Proc. Natl. Acad. Sci. USA 90:11703-11707.
15. Donnenberg, M. S., A. Donohue-Rolfe, and G. T. Keusch. 1989. Epithelial cell invasion: an overlooked property of enteropathogenic Escherichia coli (EPEC) associated with the EPEC adherence factor J. Infect. Dis. 160:452-459.
16. Donnenberg, M. S., A. Donohue-Rolfe, and G. T. Keusch. 1990. A comparison of HEp-2 cell invasion by enteropathogenic and enteroinvasive Escherichia coli. FEMS Microbiol. Lett. 69:83-86.
17. Falkow, S., P. Small, R. Isberg, S. F. Hayes, and D. A. Corwin. 1987. A molecular strategy for the study of bacterial invasion. Rev. Infect. Dis. 9 (Suppl.):S450-S455.
18. Flanigan, T. P., T. Aji, R. Marshall, R. Soave, M. Aikawa, and C. Kaetzel. 1991. Asexual development of Cryptosporidium parvum within a differentiated human enterocyte cell line. Infect. Immun. 59:234-239.
19. Fourmy, D., M. I. Recht, S. C. Blanchard, and J. D. Puglisi. 1996. Structure of the A site of Escherichia coli 16S ribosomal RNA complexed with an aminoglycoside antibiotic. Science 274:1367-1371.
20. Griffiths, J. K. 1998. Human cryptosporidiosis: epidemiology, transmission, clinical disease, treatment, and diagnosis. Adv. Parasitol. 40:37-85.
21. Griffiths, J. K., R. Moore, and S. Tzipori. Unpublished data.
22. Griffiths, J. K., R. Moore, S. Dooley, G. T. Keusch, and S. Tzipori. 1994. Cryptosporidium parvum infection of Caco-2 cell monolayers induces an apical monolayer defect, selectively increases transmonolayer permeability, and causes epithelial cell death. Infect. Immun. 62:4506-4514.
23. Griffiths, J. K., and S. Tzipori. Unpublished data.
24. Iwaki, S., K. Honke, N. Nishida, and N. Taniguchi. 1981. The absorption, excretion and influence on bowel flora of oral paromomycin sulfate. Jpn. J. Antibiot. 34:1078-1081.
25. Joiner, K. A. 1993. Vacuolar membranes surrounding intracellular pathogens: where do they come from and what do they do? Infect. Agents Dis. 2:215-219.
26. Jordan, M., A. Schallhorn, and F. M. Wurm. 1996. Transfecting mammalian cells: optimization of critical parameters affecting calcium phosphate precipitate formation. Nucleic Acids Res. 24:596-601.
27. Keusch, G. T., A. Donohue-Rolfe, M. Z. Jacewicz, and A. V. Kane. 1988. Shiga toxin: production and purification. Methods Enzymol. 165:152-161.
28. McDonald, V., M. V. McCrossan, and F. Petry. 1995. Localization of parasite antigen in Cryptosporidium parvum-infected epithelial cells using monoclonal antibodies. Parasitology 110:259-268.
29. O'Donoghue, P. J. 1995. Cryptosporidium and cryptosporidiosis in man and animals. Int. J. Parasitol. 25:139-195.
30. Oshima, M., M. Hashiguchi, M. Nakasuji, N. Shindo, and S. Shibata. 1989. Biochemical mechanisms of aminoglycoside cell toxicity. II. Accumulation of phospholipids during myeloid body formation and histological studies on myeloid bodies using twelve aminoglycoside antibiotics. J. Biochem. 106: 794-797.
31. Pieniazek, N. J., et al. Unpublished data.
32. Pinto, M., S. Robine-Leon, M.-D. Appay, M. Kedinger, N. Triadou, E. Dussaulx, B. Lacroix, P. Simon-Assman, K. Haffen, J. Fogh, and A. Zweibaum. 1983. Enterocyte-like differentiation and polarization of the human colon carcinoma cell line Caco-2 in culture. Biol. Cell 47:323-330.
33. Ranaldi, G., K. Islam, and Y. Sambuy. 1992. Epithelial cells in culture as a model for the intestinal transport of antimicrobial agents. Antimicrob. Agents Chemother. 36:1374-1381.
34. Robertson, L. J., A. T. Campbell, and H. V. Smith. 1993. In vitro excystation of Cryptosporidium parvum. Parasitology 106:13-19.
35. Schwab, J. C., C. J. M. Beckers, and K. A. Joiner. 1994. The parasitophorous vacuole membrane surrounding intracellular Toxoplasma gondii functions as a molecular sieve. Proc. Natl. Acad. Sci. USA 91:509-513.
36. Tsujimoto, Y. 1989. Overexpression of the human BCL-2 gene product results in growth enhancement of Epstein-Barr virus-immobilized B-cells. Proc. Natl. Acad. Sci. USA 86:1958-1962.
37. Tzipori, S. 1988. Cryptosporidiosis in perspective. Adv. Parasitol. 27:63-129.
38. Tzipori, S., and J. K. Griffiths. 1998. Natural history and biology of Cryptosporidium parvum. Adv. Parasitol. 40:5-36.
39. Tzipori, S., W. Rand, J. Griffiths, G. Widmer, and J. Crabb. 1994. Evaluation of an animal model system for cryptosporidiosis: therapeutic efficacy of paromomycin and hyperimmune bovine colostrum-immunoglobulin. Clin. Diagn. Lab. Immunol. 1:450-463.
40. White, A. C., Jr., C. L. Chappell, C. S. Hayat, K. T. Kimball, T. P. Flanigan, and R. W. Goodgame. 1994. Paromomycin for cryptosporidiosis and AIDS: a prospective, double-blind, trial. J. Infect. Dis. 170:419-424.
41. White, A. C., Jr., R. W. Goodgame, and C. L. Chappell. 1995. Reply. J. Infect. Dis. 171:1071. (Letter.)
42. Wilhelm, J. M., S. E. Pettitt, and J. J. Jessop. 1978. Aminoglycoside antibiotics and eukaryotic protein synthesis: stimulation of errors in the translation of natural messengers in extracts of cultured human cells. Biochemistry 17:1143-1153.